Latest filing published 17 Mar 2023 for Epigral Limited, €8,192.
Maulik Jayantibhai Patel appears in our data through filings on Epigral Limited shares, published by SEBI (PIT + SAST). The record holds 15 filings, for trades running from 29 November 2021 to 17 March 2023.
Purchases make up the whole of the open-market record (15 purchases, €751k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2023: 12 purchases and no sales on the market.
The median purchase comes to €32k. On 8 out of 14 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 17 March 2023, the filings show an open-market purchase worth €8,192 in Epigral Limited. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations